NYSE:IONQ IonQ, Inc.

ISIN: US46222L1089
TechnologyQuantum ComputingSpeculativeSpeculative · pre-profit · beta 3.2
NYSE · College Park, MD · ~407 employees · Trapped-ion quantum computing Analysis Status: Starting
$49.12
-4.4%
3 Jul 2026 · Signal v6
DISCLAIMER: This is a quantitative framework for educational purposes only. It is not financial advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

IonQ, Inc.

IonQ builds general-purpose quantum computers using trapped-ion technology — individual charged atoms suspended in electromagnetic fields and manipulated with lasers to act as qubits, an approach prized for high gate fidelity (IonQ cites ~99.99% two-qubit accuracy) and long coherence versus the superconducting chips IBM and Google favour. Customers rent time on its machines through the big cloud marketplaces (AWS Braket, Microsoft Azure Quantum, Google Cloud) and IonQ's own cloud, and it is extending into quantum networking and sensing via a fast run of acquisitions (Oxford Ionics, ID Quantique, Capella). What sets it apart is being one of the very few pure-play, publicly-traded quantum names with a working commercial cloud offering and a fortress balance sheet (~$3.1B cash & investments). The catch for a reader: revenue is still tiny (~$187M trailing) against an ~$18B market value, the company loses heavily at the operating line, and useful fault-tolerant quantum computing is widely expected only around 2028–2032 — so this is a long-dated, high-risk technology bet, not a cash-generating business.

HorizonSignalComposite ScoreConfidenceKey Driver
Short-term (1–3 mo)HOLD4248%extreme valuation caps; bearish daily tape
Medium-term (6–12 mo)HOLD4550%valuation ceiling + dilution gates
Long-term (3–5 yr)HOLD4748%real secular driver, priced for perfection
Next update: 2026-07-17 — default +14d — no outlook-changing event inside the 2-week window (late-Jul FOMC ~29-30 Jul and Q2 earnings ~6 Aug both fall just outside); a high-beta spec name is re-checked on the 2-week cap.
Table of Contents
1Five-Pillar Scorecard2Hard Gates & Do-Not-Buy Status3Pillar Detail: Business Quality4Pillar Detail: Valuation Attractiveness5Pillar Detail: Underlying Drivers6Pillar Detail: Economic Alignment7Pillar Detail: Entry/Exit Timing8Economic Event Risk9Multi-Timeframe Technical Analysis10Price Chart (6-Month Daily)11Scenario Summary12Entry / Exit Rules13Position Sizing Context14Calibration Snapshot15Data Sources & Methodology
1

Five-Pillar Scorecard

Five independent scores — each 0–100 with its own confidence. The three fundamental pillars (Quality / Valuation / Timing) set the base BUY/HOLD/SELL via the Decision Matrix; the two context pillars (Underlying Drivers, Economic Alignment) then amplify a BUY to STRONG BUY or a SELL to STRONG SELL when both corroborate.

Business Quality

44
speculative / early-revenue
conf 55%

Valuation Attractiveness

20
extreme
conf 65%

Entry/Exit Timing

40
bearish tilt
conf 55%

Underlying Drivers

62
Moderate Tailwind
conf 55%

Economic Alignment

55
Trend-Following
conf 55%
2

Hard Gates & Do-Not-Buy Status

Binary safety checks — any TRIGGERED gate is a hard cap regardless of the scores above; CAUTION gates are sizing notes.
⚠️
Gate 1 — Financial Distress
Zero debt, ~$3.1B cash & investments (cash/share $5.67), current ratio 14x — no solvency risk. BUT the Gate-1 'negative FCF 4+ quarters with no clear path to positive' arm is technically met: operating loss was -$271.5M in Q1'26 on $64.7M revenue, and consensus shows the company still loss-making through 2030. Not hard-tripped to HOLD because the ~$3.1B liquidity funds ~9 years of the guided ~$(320)M adjusted-EBITDA burn. Flagged as a caution, not a distress block.
Gate 2 — Earnings Event Risk
Q2 2026 results expected ~6 Aug 2026 — outside the 14-day window. No binary earnings gate today, but the print is the next major catalyst and the reason for the near-term re-check.
Gate 3 — Valuation Ceiling
TRIGGERED. EV/Revenue ≈ 57–68x on FY26 guided revenue ($260–270M) and ≈ 81–96x trailing ($187M) — 3–5x the Information-Technology guardrail line (EV/Rev ≥ 20x). Price also sits above the $48.5 low analyst target. Caps the signal at HOLD maximum regardless of momentum.
Gate 4 — Dilution / Accounting
TRIGGERED on three counts: (1) share count grew ~65% YoY (218M → 359M weighted) via ~$2.5B of mostly-stock M&A; (2) stock-based comp of $128.5M in Q1'26 is ~200% of revenue (tech red-flag line is 25%); (3) reported Q1 net income of +$805M is an accounting artefact — it embeds a +$1.1B non-cash warrant mark-to-market gain, so headline P/E (545x) and EPS are meaningless. Score everything on operating results. Caps at HOLD.
Gate 5 — Regulatory / Binary Event
No pending FDA / antitrust / regulatory binary. Technology-milestone risk is continuous, not a single dated binary.
Do-Not-Buy triggers — the arm-(a) near-miss (deliberate call). DNB Trigger 2 absolute arm (a) — 'deep-expensive alone: actual multiple ≥ 1.5× the sector guardrail line (30x EV/Rev) with no exceptional, proven, durable growth' — numerically qualifies: at 57–95x EV/Rev IONQ is 2–3x past even that 30x threshold. It is not fired to a hard DO-NOT-BUY, as a deliberate analyst judgment, held back only by the fact that the top-line growth is genuinely exceptional and proven (+755% YoY) and backed by $470M of contracted remaining performance obligations (+554% YoY) — i.e. booked backlog, not pure momentum — which supplies real (if 1–2-yr, not rate-durable) forward visibility. This is a hair from a hard prohibition: a single guidance cut, an RPO stall, or a missed roadmap milestone flips it to DO-NOT-BUY on the next refresh. The $3.1B cash cushion is not a reason to withhold the trigger (that bears on Gate 1, not on valuation-extremity). DNB Trigger 4 (insider selling) is clear: the 2026 Form-4 activity is routine RSU tax-withholding and pre-arranged 10b5-1 open-market sales in the low thousands of shares (CEO/CFO/directors, ~$0.2M-scale), not the '3+ C-suite selling >25% of holdings, non-10b5-1' pattern. Triggers 1 (leverage), 3 (negative revisions — estimates are rising) and 5 (structural threat — competition is a slow risk, not a live catalyst) do not fire. Net: capped at HOLD by Gates 3 + 4, no DNB banner.
3

Pillar Detail: Business Quality

A deep dive into the Quality score: business economics, moat, ROIC and the industry benchmark.
Business Quality — Pillar Score
A technology leader with a fortress balance sheet, but a deeply-unprofitable early-revenue business whose growth is heavily acquisition-driven
44
conf 55%

Lifecycle: Early-revenue / speculative (deeply pre-profit). IonQ is scored on the pre-profit Technology lens — revenue trajectory, cash runway, gross margin, dilution and moat — not on P/E, ROE or net margin, all of which are distorted by a +$1.1B non-cash warrant gain (see Gate 4). Reported TTM net margin (+148%) and P/E (545x) are accounting noise; the operating line is the truth: an operating loss of -$271.5M in Q1'26 against $64.7M of revenue — the business spends roughly four dollars for every dollar it books.

Sub-signalReadingScore
Revenue trajectoryQ1'26 $64.7M, +755% YoY; FY26 guide raised to $260–270M; RPO $470M (+554%). Exceptional — but a large share is inorganic (Oxford Ionics / ID Quantique / Capella) and lumpy government contracts on a tiny base.78
Profitability (operating)Operating margin ≈ -420%; guided adj-EBITDA loss $(330)–(310)M for FY26; consensus shows net losses continuing through 2030 (2030 net income est. ≈ -$414M). No profitability in the modelled horizon.10
Cash generationFCF persistently negative (FCF/share ≈ -$1.18 TTM). Offset by ~$3.1B cash & investments — ~9-yr runway, so no near-term dilution pressure, but no self-funding either.28
Balance-sheet healthEffectively debt-free (D/E 0.006), current ratio 14x, cash/share $5.67. The single strongest pillar of the whole name.90
Dilution / SBCShares +65% YoY; SBC $128.5M/quarter ≈ 200% of revenue. Shareholders are being diluted aggressively to fund R&D and M&A.14
Industry benchmark (pre-revenue tech: cash runway + commercialisation stage). Runway >24 months (≈9 yrs) scores at the top of the survival axis, but the commercialisation axis is weak — useful, fault-tolerant quantum advantage is an industry-consensus 2028–2032 event, so IonQ is pre-commercial-inflection. Blended benchmark ≈ 40/100: it will not run out of money, but the payoff is distant and unproven.

Pricing power

50 — cloud access is metered against IBM/Google/AWS-hosted alternatives; no demonstrated pricing power at this stage.

Network effects

45 — some developer-ecosystem pull via the cloud marketplaces, but multi-vendor back-ends (Azure Quantum hosts IonQ, Quantinuum and Rigetti) blunt lock-in.

Switching costs

40 — algorithms are largely portable across back-ends; customers can and do multi-home. Derived directly from the Competitive Environment read below.

Cost advantage

45 — trapped-ion fidelity edge is real, but Quantinuum (also trapped-ion) is a credible cost/quality peer; superconducting rivals scale qubit counts faster.

Intangible assets

68 — genuine IP moat: fidelity leadership plus Oxford Ionics' semiconductor-manufacturable ion-trap patents. The strongest moat dimension.

Moat average ≈ 50/100 — an IP-and-fidelity lead that is real but contested, with weak lock-in.

Competitive Environment (mandatory). IonQ competes on two fronts. Same-technology (trapped-ion): Quantinuum (Honeywell/Cambridge Quantum) is arguably the strongest trapped-ion competitor on system quality and is pursuing its own listing; Oxford Ionics was a rival IonQ neutralised by acquiring it. Different-technology: IBM and Google Quantum AI (superconducting) lead on raw qubit counts, roadmaps and balance-sheet depth; PsiQuantum (photonic, well-funded private) is chasing fault-tolerance directly; Rigetti (RGTI, superconducting) and D-Wave (QBTS, annealing) are the other listed pure-plays; Infleqtion (neutral-atom) is an emerging private rival. Share trajectory: there is no established market share to defend yet — the whole industry is pre-commercial — so 'moat' here is a bet on which architecture reaches useful error-corrected scale first. IonQ's fidelity lead and full-stack (compute + networking + sensing) breadth are advantages; its dependence on cloud partners who also host rivals, and the deep pockets of IBM/Google/PsiQuantum, are the offsetting threats. This read caps Switching Costs (40) and Cost Advantage (45) and feeds the §11 Bear and §12 thesis-invalidation (a competitor reaching logical-qubit advantage first is the core structural risk).

ROIC & capital allocation: ROIC is deeply negative and not meaningful pre-profit. Capital allocation is the debate: management has deployed ~$2.5B of (mostly stock) into 18 months of M&A to assemble a full-stack quantum platform — visionary if quantum commercialises on their timeline, value-destructive dilution if it does not. FMP financial-health rating B (overall 3/5) with DCF and P/E sub-scores at the floor (1/5) — consistent with 'solid balance sheet, no earnings support'. Net Quality 44: a technology and balance-sheet story wrapped around an unproven, cash-consuming business.

4

Pillar Detail: Valuation Attractiveness

Sector-appropriate multiples, FCF yield, reverse-DCF implied growth, embedded optionality, and the analyst-consensus cross-check.
Valuation Attractiveness — Pillar Score
Genuinely valuation-extreme — one of the most expensive revenue multiples in the market, with no earnings anchor
20
conf 65%

Warranted-multiple anchor: N/A — IonQ is pre-profit with no reliable earnings multiple, so the P/E-based warranted anchor cannot be computed (recorded as warranted_multiple: "na"). Valuation is therefore scored on EV/Revenue against the sector guardrail floor, which is exactly the case the floor exists for. Because the reported P/E (545x) and net margin are inflated by the +$1.1B non-cash warrant gain, no earnings-based lens is used at all.

LensReadingVerdict
EV/Revenue vs guardrail (THE anchor here)EV ≈ $15–18B (mkt cap $18.3B less ~$3.1B net cash; FMP TTM EV $17.9B). ÷ FY26 guided rev $265M = ≈ 57–68x forward; ÷ trailing $187M = ≈ 81–96x. IT guardrail 'rich' line is EV/Rev ≥ 20x.Expensive — 3–5x the line
Price/Sales (TTM)98x (FMP).Extreme
Own-history decileOff a Jan-2021 SPAC listing the multiple has spent its whole life in nosebleed territory; even by its own range this is upper-decile.Extreme (0–9)
PEG-style (growth-adjusted)Growth is high, but on a tiny base and with no path to earnings — a growth-adjusted read cannot rescue a 57x+ forward revenue multiple with negative and widening losses.Poor
Analyst target & consensus (subordinate)Consensus $67.13 / median $67.5 / high $85 / low $48.5 (6 analysts). Price $49.12 is ~27% below consensus — the one bullish valuation signal — and grades split 3 Buy / 3 Hold ('Buy', 50% bullish).Mild positive
FCF yieldNegative (FCF/share ≈ -$1.18). N/A as a value anchor.N/A

How the sub-signals net. Per the framework, the relative cross-checks (including the ~27%-below-consensus analyst signal) can only order the name within the band the anchor/guardrail sets — they cannot lift an Expensive name into Fair. The guardrail floor is dispositive: at 57–95x EV/Rev the name is squarely in the Expensive band (val_band = expensive), which routes the Decision Matrix to its Expensive column (→ HOLD) and arms Gate 3. Score 20/100.

Implied-growth read (narrative colour). To justify $49 on any normal software multiple (say a rich 12x EV/Sales on mature quantum revenue), IonQ would need revenue of ~$1.3B — roughly its own analyst 2030 revenue estimate ($1.29B) — and to be generating cash by then, which consensus says it will not be. In other words the price already discounts flawless execution most of the way to the decade's end. The market is not paying for today's business; it is paying for a 2030+ option.
Embedded Optionality / Free Upside. The bull case is almost entirely optionality, so name it honestly: (1) Quantum networking & sensing — the ID Quantique / Capella assets (QKD, space-based key distribution) are pre-monetisation and carried at ~0 in any revenue multiple; a real government/defence networking contract could re-rate them. (2) Fault-tolerant milestone — hitting the 2027 ">10,000 physical qubit" roadmap step ahead of superconducting rivals would be a genuine re-rating catalyst. (3) Strategic takeout — a fortress-balance-sheet, IP-rich pure-play is a plausible target for a hyperscaler or defence prime. Discipline check: these are call options the buyer is paying a large premium for, not reasons the stock is cheap. Optionality is the reason to watch, not a reason the core is undervalued — it does not move the Expensive band.
5

Pillar Detail: Underlying Drivers

The dominant external force the stock is tethered to, scored 0–100. A context pillar: it does not change the base signal — it feeds amplification (tailwind ≥65 can lift BUY→STRONG BUY; headwind ≤35 can push SELL→STRONG SELL).
Primary Driver
Quantum-computing commercialisation (+ government/defence + quantum networking)
62
Moderate Tailwind — cannot amplify a HOLD

IonQ's fortunes sit almost entirely above its own execution, on the pace of quantum-computing commercialisation and the government/defence and quantum-networking spend that funds the industry pre-revenue. This is not a commodity-price driver; it is a technology-adoption-and-funding driver, so it is read on trajectory and funding flow rather than a spot price.

HorizonDriver stateScore
Short (0–4 wk)Quantum-stock sentiment has cooled — IONQ is ~40% off its late-May high and the daily tape is in a downtrend. Momentum has rotated out short-term.48
Medium (1–6 mo)Raised FY26 guidance, $470M RPO and a steady contract/announcement cadence (networking, defence, cloud) keep the narrative alive; offset by no commercialisation inflection and rich-multiple fragility.60
Long (6–18 mo+)Large secular TAM and sustained government funding; the 2028–2032 fault-tolerance window is the prize. Strong but distant and unproven — and shared with deep-pocketed rivals.72

Amplification note: the blended driver score of 62 is a moderate tailwind (≥65 would be a strong tailwind). Critically, amplification only intensifies a BUY or SELL base signal — it never amplifies a HOLD. Since valuation routes every horizon to a HOLD base (and Gates 3/4 cap at HOLD regardless), the driver tailwind is documented but does not lift the signal. It is the reason the name is a Watch rather than an Avoid.

6

Pillar Detail: Economic Alignment

How the current economic climate sits relative to this stock, read from the latest Macro-Economic report. Classifies the macro pressure (Tailwind / Neutral / Headwind) — the second amplification input — and frames a long entry as Trend-Following or Contrarian with a 0–100 conviction.
Stance · Pressure
Trend-Following · Tailwind
55
conviction

Macro regime is Contested (Soft Landing / Stagflation co-lead 30/30, Reaccel 27, Defensive Bust 13; confidence Low-Med). Risk appetite is currently risk-on (VIX 16.59), UST10Y 4.48%, unemployment 4.2%, June NFP +57k. IonQ sits in Technology / XLK, which the macro map scores Outperform across Short/Medium/Long — a mild tailwind, so the stance is Trend-Following (aligned with the sector wind) rather than Contrarian. Conviction is deliberately tempered to 55 (from a higher raw sector read) for two reasons: (1) the valuation is extreme, which makes any single high-beta name far more fragile than the sector aggregate; and (2) the regime is Contested with an armed — though not-triggering, and currently falsifying as breadth broadens — 'S&P 500 concentration / AI-unwind' tail. IonQ is a loss-making mid-cap spec, NOT an index-top-weight name on non-operating-inflated earnings, so it is explicitly NOT in that tail's cohort — the systemic tail is not forced onto this name (though a general risk-off would hit it hard idiosyncratically; see §11 Bear).

Source: sector-map · Macro report 2026-07-03

7

Pillar Detail: Entry/Exit Timing

The risk-reward framework, relative strength vs SPY and the sector ETF, the macro overlay, news-derived sentiment, and the catalyst cluster.
Entry/Exit Timing — Pillar Score
A bearish daily tape into an extreme valuation — the wrong side of the risk-reward for a new entry
40
conf 55%

Timing blends the multi-timeframe trend (30%), the risk-reward setup (20%), and — at the low macro-sensitivity weighting appropriate for a niche technology name (macro 10% / sentiment 20% / catalyst 20%) — the macro overlay, sentiment and catalyst layers.

ComponentReadingScore
MTF trend (30%)Confluence bearish: monthly/weekly uptrend but daily broke support, hourly/15-min strong downtrend; sitting on the 200-DMA (~$49.6). See §9.42
Risk-reward setup (20%)Nearest logical stop is the $39.8 support (~$9, ~1.8 ATR of $5.05 away) while overhead supply sits at $54–55 (50-DMA / broken support) — an unfavourable ~1:0.6 setup from here. Better entry is lower ($40) or on a confirmed $55 reclaim.38
Relative strength~40% below the late-May $72 high; underperforming its own recent trend and rolling over vs a risk-on XLK. Mid-range of the 52-wk band ($25.89–$84.64).40
Macro overlay (10%)VIX 16.6 risk-on and a Tech/XLK tailwind are supportive, but a long-duration name is exposed to the CPI→FOMC rate path in late July.55
Sentiment (20%)News tone mixed-to-cautious ('down 40% from ATH', 'high-risk'); analyst grade actions are stale (2023–24), so recency-weighted near zero. Retail enthusiasm has cooled.42
Catalyst (20%)Clustered CPI + FOMC + Q2 earnings in late-Jul/early-Aug — path risk is elevated, which argues for smaller size / waiting, not chasing.40

Timing = 40. The higher-timeframe uptrend keeps this from being an outright SELL tape, but the daily breakdown, the unfavourable risk-reward from $49 into $55 resistance, and the clustered event risk all say this is not an entry point. For a holder it is a 'manage the stop' tape; for a new buyer it is a 'wait for $40 or a $55 reclaim' tape.

8

Economic Event Risk

High-impact macro releases in the next 14 days that could swing this stock, plus the last 7 days of surprises.

Upcoming events (next 30 days)

DateEventImpactForecastPreviousRelevant?Why
~2026-07-15US CPI (Jun)High~2.9% YoY2.9%MediumGrowth-stock valuations are rate-sensitive; a hot print lifts the 10Y and pressures long-duration names like IONQ.
~2026-07-29/30FOMC rate decisionHighHoldHoldMediumRate path drives the discount rate on far-future cash flows — the whole IONQ thesis is long-duration.
~2026-08-06IonQ Q2 2026 earningsHighRev $65–68M (guide)$64.7MYesThe key idiosyncratic catalyst — guidance, RPO trajectory and burn are what move a pre-profit spec name.

Recent surprises (last 7 days)

DateEventActualForecastSurpriseImpact
2026-07-02Nonfarm Payrolls (Jun)+57k~+80kMissMild risk-off; softens the labour picture but not decisive for a non-cyclical spec.
2026-05-07IonQ Q1 2026 resultsRev $64.7M / guide raised$49.7M consLarge beatDrove the May run to ~$72 before the June fade.

No high-impact macro event inside the 14-day window. The clustered CPI → FOMC → Q2-earnings sequence in late-Jul/early-Aug is why the next re-check is set at the 2-week cap and why timing confidence is held modest.

9

Multi-Timeframe Technical Analysis

Trend, RSI and breakout status across monthly / weekly / daily / hourly / 15-minute, with a confluence verdict.
TimeframeTrendDirectionRSIMACDKey S/RBreakoutVol
MonthlyUptrend ↑Bullish55.8+, flatS: $21.6 R: $84.6Resist. breakout0.1x
WeeklyUptrend ↑Neutral50.7+, risingS: $25.9 R: $54.2None0.5x
DailyDowntrend ↓Bearish41.0-, fallingS: $39.8 R: $54.8Support breakdown0.6x
HourlyStrong down ↓Bearish39.7-, fallingS: $48.2 R: $54.8Support breakdown0.0x
15-minStrong down ↓Neutral49.1flatteningS: $48.2 R: $54.4None0.0x
Confluence: Bearish (higher-TF uptrend, lower-TF rolling over) · MTF Score 42

A textbook higher-timeframe-bullish / lower-timeframe-breakdown split. Monthly and weekly remain in secular uptrends (the stock is up multiples over two years), but the daily has broken support with a falling MACD and sits right on its 200-DMA (~$49.6), the hourly and 15-min are in strong downtrends, and the name is ~40% below its late-May $72 high. Net confluence is bearish — rallies into the $54–55 (50-DMA / broken-support) zone are where supply is, and the $39.8 daily support is the line that matters on the downside. This is a 'sell-the-rip in a short-term downtrend' tape, not a dip-buy setup — consistent with the Timing pillar at 40.

10

Price Chart (6-Month Daily)

A 6-month daily close line with SMA50 and key support/resistance — the visual companion to the MTF table.

IONQ daily closes, Jan–Jul 2026 (sampled). The Feb sell-off to ~$26, the Apr–May run to ~$72, and the June fade back to $49 — now on the 200-DMA with the daily broken to the downside. 52-wk range $25.89–$84.64; beta 3.18.

11

Scenario Summary

Bull / Base / Bear 12-month price paths with triggers and probability weights.

Bull $78 (25%)

A hard re-rating catalyst lands: a marquee government/defence or quantum-networking contract, or a roadmap milestone (progress toward the 2027 >10,000-physical-qubit target) that the market reads as pulling fault-tolerance forward relative to superconducting rivals. Risk-on persists (VIX low, XLK bid), the $470M RPO keeps compounding, and the multiple re-expands toward the prior $84 high. High-beta (3.2) means a thesis-confirming quarter can move it 50%+ quickly. This is an option paying off, not a change in the valuation math.

Base $50 (50%)

IonQ delivers into its raised FY26 guide ($260–270M) and keeps announcing contracts, but shows no commercialisation inflection and no path to profit — losses widen as guided. The extreme EV/Rev multiple neither fully corrects (the balance sheet and growth narrative support it) nor expands (nothing forces a re-rate). The stock chops in a wide $42–58 band around the 200-DMA, roughly flat to today over 12 months. HOLD is the honest base case: real driver, real backlog, priced for perfection.

Bear $25 (25%)

The severe idiosyncratic de-rating the framework demands for a spec name on an extreme multiple. Any of: a guidance cut or RPO stall, a broad growth-stock/risk-off rotation (the Contested regime's downside), a competitor (Quantinuum, IBM, Google, PsiQuantum) claiming a logical-qubit advantage first, or continued relentless dilution souring sentiment. At 57–95x EV/Rev there is no earnings floor to catch it — mean-reversion is a 50%+ move, back toward the $25.89 52-wk low. This is the scenario that flips DNB arm-(a) live and would take the name to DO-NOT-BUY. Note: this is company/cohort-idiosyncratic risk, NOT the macro 'AI-concentration unwind' tail (IONQ is not in that cohort).

Probability-weighted fair value ≈ 0.25×$78 + 0.50×$50 + 0.25×$25 = ≈ $50.75 — essentially the current price, with a fat left tail. The distribution is barbelled (a distant option vs a deep de-rating), which is the signature of a speculative lottery-ticket holding. Analyst fair-value anchor used in §12: ~$40 (a deliberate discount to the $67 consensus, reflecting the Expensive band).

12

Entry / Exit Rules

Three independent entry paths (Fundamental · Technical · Catalyst) and three exit triggers (Stop-Loss · Thesis · Profit-Target). Any one entry path is a valid entry — the more that agree, the larger the position the conviction ladder suggests. Exits are graded by severity, not count.

How to read this — the Conviction Ladder

The three entry groups are alternative paths to a buy, not a checklist. A group counts only when all its sub-conditions hold. How many groups are satisfied sets the suggested size — it does not gate whether you may enter: 1 group = Half-Size (a valid starter/scale-in), 2 = Full-Size, 3 = Over-Size (highest conviction); 0 = Wait (no path open yet). A strong overall signal can still read Wait here when the stock is well above its entry zones — that flags "good business, no entry edge right now," not a contradiction. Exits are graded by severity of what is live, not by a count: a hard stop is an Exit on its own.
Entry conviction: Wait0 of 3 groups met — no entry path open

Fundamental — not MET

Price is above our fair-value estimate and the name is in the Expensive valuation band — the fundamental gate for a new entry is not open.
⛔ Price $49.12 ≤ fair value ~$40
⛔ Valuation band not Expensive (it is Expensive — EV/Rev 57–95x vs 20x line)
✅ Underlying-Driver score ≥ 50 (62)
✅ No earnings within 7 days (next ~6 Aug)

Technical — not MET

Daily is in a downtrend below the 50-DMA with a support breakdown; preferred entry would be a reclaim of $55 OR a tested bounce off $40 support.
⛔ Daily close > 50-DMA ($54.96) on >1.5x volume
⛔ OR a tested higher-low bounce off $39.8–$40 support
✅ RSI 35–65 (41.0)

Catalyst — not MET

No positive catalyst inside the window; the next event (Q2 earnings ~6 Aug) is itself a binary risk, not a confirmed entry trigger.
· Post-earnings move >+5% with guidance raised
⛔ Confirmed government/defence or networking contract re-rate

Forecast: No entry group is met (0/3) → Conviction Ladder = WAIT. For a fundamentally-driven entry the name would need to de-rate toward ~$40 (into the Expensive→Full boundary) — not visible on a 4–6-week horizon absent a broad risk-off. For a purely technical/tactical trade, the trigger is either a high-volume daily reclaim of $55 (could come within 2–4 weeks on a positive catalyst) or a tested higher-low bounce off $40. Until one prints, this is a Watch, not a Buy.

Exit action: Holdno exit trigger is live — hold the position

Stop-Loss — not LIVE

⛔ Two daily closes below $39 (below the $39.8 daily-support shelf)

Thesis Invalidation — not LIVE

⛔ A competitor (Quantinuum / IBM / Google / PsiQuantum) demonstrably reaches logical-qubit/error-corrected advantage first
⛔ OR a guidance cut / RPO decline signalling the growth ramp is stalling
⛔ OR dilution accelerates (another large stock-funded raise/M&A) with no revenue payoff

Profit-Target — not LIVE

⛔ Price into $78 (bull) with RSI > 70 — trim into strength given the extreme multiple

Forecast: No exit condition is live (holder view). Price is ~24% above the $39 stop; on a 3.2-beta name that buffer can evaporate in days, so the stop is a real risk, not a remote one. Thesis-invalidation legs are slow-moving (competitive/roadmap) and would be flagged well before they resolve.

Imagine you act at the current price of $49.12 · as of 3 Jul 2026

What if you bought now?

A new buyer here is paying 57–95x revenue for a business that loses ~4x its revenue and won't earn a profit this decade — risking ~24% to the $39 stop against a barbelled payoff. Only defensible as a small, sized-down speculative option, entered on weakness toward $40 or a confirmed $55 reclaim — not at market into a bearish daily tape.

What if you sold now?

A holder isn't forced out — no exit leg is live and the secular driver is intact. But given the Expensive band and the near-miss DNB, trimming into any $70+ strength and honouring the $39 stop is the disciplined path. This is a position to manage tightly, not to marry.
13

Position Sizing Context

Illustrative portfolio math (not advice) translating conviction into an allocation given risk-per-share and volatility.
not computed
14

Calibration Snapshot

Machine-readable snapshot of every score, level and signal, saved alongside the HTML so the next run can compute deltas.
{
  "ticker": "IONQ",
  "exchange": "NYSE",
  "exchange_ticker": "NYSE:IONQ",
  "isin": "US46222L1089",
  "api_ticker": "IONQ",
  "company": "IonQ, Inc.",
  "sector": "Technology",
  "sub_industry": "Quantum computing (trapped-ion) hardware + cloud + networking",
  "lifecycle_stage": "early-revenue / speculative (deeply pre-profit)",
  "analysis_status": "donatien-pick",
  "user_horizon": null,
  "user_allocation_pct": null,
  "portfolio_role": null,
  "date": "2026-07-03",
  "version": "v6",
  "macro_report_date": "2026-07-03",
  "economic_alignment_source": "sector-map",
  "economic_alignment_stance": "Trend-Following",
  "economic_alignment_pressure": "Tailwind",
  "economic_alignment_conviction": 55,
  "sector_map": "XLK \u2192 Outperform (Short/Medium/Long); tempered for extreme valuation + Contested regime",
  "signals": {
    "short": {
      "signal": "HOLD",
      "score": 42,
      "confidence": 48
    },
    "medium": {
      "signal": "HOLD",
      "score": 45,
      "confidence": 50
    },
    "long": {
      "signal": "HOLD",
      "score": 47,
      "confidence": 48
    }
  },
  "pillars": {
    "business_quality": {
      "score": 44,
      "confidence": 55
    },
    "valuation": {
      "score": 20,
      "confidence": 65
    },
    "timing": {
      "score": 40,
      "confidence": 55
    },
    "drivers": {
      "score": 62,
      "confidence": 55
    },
    "economic_alignment": {
      "score": 55,
      "confidence": 55
    }
  },
  "warranted_multiple": "na",
  "actual_multiple": 62.0,
  "val_multiple_basis": "EV/Revenue (forward, FY26 guide $265M) \u2014 pre-profit, no clean P/E; guardrail floor governs",
  "discount_rate_r": "na (pre-profit \u2014 anchor not computed)",
  "risk_free_10y": 4.48,
  "g_near": "na (pre-profit)",
  "g_term": "na (pre-profit)",
  "warranted_ratio": "na",
  "val_band": "expensive",
  "ev_rev_forward": 62.0,
  "ev_rev_trailing": 88.0,
  "sector_guardrail_line_ev_rev": 20,
  "competitive_named_rivals": [
    "Quantinuum",
    "IBM",
    "Google Quantum AI",
    "PsiQuantum",
    "Rigetti (RGTI)",
    "D-Wave (QBTS)",
    "Infleqtion",
    "Oxford Ionics (acquired)"
  ],
  "competitive_share_trajectory": "Pre-commercial industry, no established share to defend; race is which architecture reaches useful error-corrected scale first (~2028\u20132032). IonQ: fidelity/full-stack advantage vs deep-pocketed superconducting (IBM/Google) and photonic (PsiQuantum) rivals and trapped-ion peer Quantinuum.",
  "competitive_moat_avg": 50,
  "gates": {
    "financial_distress": "caution (neg-FCF arm met but ~9yr cash runway offsets)",
    "earnings_event": "clear (Q2 ~6 Aug, outside 14d)",
    "valuation_ceiling": "triggered (EV/Rev 57\u201396x \u2265 20x IT guardrail; caps at HOLD)",
    "dilution_accounting": "triggered (+65% YoY shares; SBC ~200% of rev; +$1.1B non-op warrant gain inflates net income; caps at HOLD)",
    "regulatory_binary": "clear"
  },
  "dnb_triggers": {
    "trigger_1_leverage": "clear (net cash)",
    "trigger_2_valuation_extreme": "NEAR-MISS \u2014 arm (a) numerically qualifies (57\u201395x EV/Rev is \u22651.5\u00d7 the 30x threshold) but NOT fired, held back deliberately by exceptional+proven top-line growth + $470M contracted RPO; arm (b) not fired (no live structural threat; IONQ not in AI-concentration cohort so systemic tail not inherited). A hair from DO-NOT-BUY.",
    "trigger_3_negative_revisions": "clear (estimates rising)",
    "trigger_4_insider_selling": "clear (routine RSU-tax / pre-arranged 10b5-1 sales, low-thousands of shares; not the >25%-of-holdings non-plan pattern)",
    "trigger_5_structural_threat": "clear (competition is a slow risk, not a live catalyst)"
  },
  "dnb_fired": false,
  "signal_override_chain": "Base matrix (Expensive col \u2192 HOLD) \u2192 amplification (HOLD not amplified) \u2192 Gates 3+4 cap at HOLD \u2192 no DNB \u2192 final HOLD all horizons",
  "price_at_rating": 49.12,
  "fair_value_estimate": 40,
  "stop_loss": 39,
  "scenario_base_target": 50,
  "scenario_bull_target": 78,
  "scenario_bear_target": 25,
  "scenario_probabilities": {
    "bull": 25,
    "base": 50,
    "bear": 25
  },
  "scenario_weighted_fair_value": 50.75,
  "entry_groups_met": 0,
  "entry_conviction": "Wait",
  "exit_groups_live": 0,
  "exit_action": "Hold",
  "next_update_date": "2026-07-17",
  "next_update_basis": "default +14d \u2014 no outlook-changing event inside the 2-week window (FOMC ~29-30 Jul, Q2 earnings ~6 Aug both just outside); high-beta spec re-checked at the cap",
  "key_financials": {
    "price": 49.12,
    "market_cap": 18335019846,
    "enterprise_value_fmp_ttm": 17871924846,
    "cash_and_investments": 3100000000,
    "ttm_revenue": 187118000,
    "fy26_revenue_guide": "260-270M",
    "q1_2026_revenue": 64668000,
    "q1_2026_revenue_growth_yoy": "+755%",
    "q1_2026_operating_income": -271507000,
    "q1_2026_reported_net_income": 805360000,
    "q1_2026_nonop_warrant_gain": 1100000000,
    "fy26_adj_ebitda_loss_guide": "-330M to -310M",
    "rpo": 470000000,
    "rpo_growth_yoy": "+554%",
    "sbc_q1_2026": 128500000,
    "shares_wtd_q1_2026": 358822219,
    "shares_wtd_q4_2024": 217948000,
    "beta": 3.184,
    "price_target_consensus": 67.13,
    "price_target_high": 85,
    "price_target_low": 48.5,
    "grades": "3 Buy / 3 Hold (Buy)",
    "fmp_health_rating": "B (3/5)"
  }
}

First report — coverage initiated as a Donatien Pick (operator conviction add; permanent hold until manually removed, protected from finder-sync Stops). Signal HOLD across all three horizons: a base HOLD from the Expensive valuation column, with Gates 3 (Valuation Ceiling) and 4 (Dilution/Accounting) both firing to cap at HOLD, and DNB Trigger 2 arm-(a) a deliberate near-miss (held back only by the $470M contracted RPO + exceptional proven top-line growth). Real secular driver, fortress balance sheet, genuinely extreme valuation — a speculative Watch.

15

Data Sources & Methodology

Audit trail of every data source: fully available (✓), fallback (⚠), or failed (✗), plus provenance-based confidence haircuts.
Data Source Status
get_company_profile identity, sector, ISIN US46222L1089, mkt cap $18.3B, beta 3.18, price $49.12
get_income_statement (6q) revenue ramp $7.6M→$64.7M; operating loss -$271.5M Q1'26; +$1.1B non-op warrant gain isolated
get_financial_ratios P/S 98x, EV $17.9B, cash/share $5.67, current ratio 14x, D/E 0.006; P/E 545x flagged as artefact
get_multi_timeframe_analysis confluence bearish; daily downtrend/support breakdown on the 200-DMA
get_stock_prices (6mo daily) 125 bars — chart series and S/R levels
get_price_target_consensus cons $67.13 / med $67.5 / high $85 / low $48.5
get_grades_consensus / get_stock_grades 3 Buy / 3 Hold ('Buy'); individual grade actions stale (2023–24) — sentiment weighted down for recency
get_analyst_estimates FY26 rev ~$266M; net losses through 2030 (2030 NI est ≈ -$414M) — anchors the 'no profit this decade' read
get_ratings_snapshot FMP health B (3/5); DCF & P/E sub-scores 1/5
get_earnings_calendar no output; earnings date (~6 Aug) sourced from web/prior-year cadence
get_polygon_news 15 articles; Q1 beat, 'down 40% from ATH', high-risk framing
WebSearch (guidance/cash/M&A/competitive/insiders) $3.1B cash; FY26 guide $260–270M; adj-EBITDA loss $(330)–(310)M; RPO $470M; ~$2.5B M&A / dilution; insider sales routine RSU-tax/10b5-1
Impact on scores: High confidence on the valuation-extreme conclusion (multiple, dilution and non-operating-gain facts are hard-sourced). Main uncertainties are the exact earnings date (calendar tool empty) and the durability of the growth rate (the crux of the DNB arm-(a) near-miss) — both flagged.
DISCLAIMER: This is a quantitative framework for educational purposes only. It is not financial advice. Always do your own research and consult a licensed financial advisor before making investment decisions.